Background: Blast is a devastating disease in rice production. The current research tested the efficacy of biologicals and fungicides against blast. Aqueous extracts of Azadirachta indica, Ocimum basalicum, Cymbopogan flexousus, Thymus vulgaris, Aloe vera, Tagetes patula, Cordia curassavica, Aegle marmelos, Allium fistulosum, Syzygium aromaticum, and Calotropis gigantea were tested in vitro at 5, 10, and 15% concentrations against Magnaporthe oryzae. Also, two isolates, Bacillus cereus OG2L and B. subtilis OG2A, and one isolate, Azotobacter SAG19, and, similarly, five new generation fungicides were evaluated at three different doses against blast pathogen M. oryzae in vitro. The treatments that exhibited the best performance in vitro were further evaluated against blast disease under field conditions.Results: Extracts of T. patula (5%), C. gigantea (5%), C. curassavica (10%), A. fistulosum (10%), and A. marmelos (15%) showed greater than 81% inhibition to M. oryzae in vitro. Likewise, all three biocontrol agents, viz. B. cereus OG2L, B. subtilis OG2A, and Azotobacter SAG19, demonstrated more than 50% inhibition of mycelial growth of pathogen in vitro, and the commercial formulations of fungicides Propineb, Trifloxystrobin+Tebuconazole, Tebuconazol+Triadimenol, Bacillus subtilis Strain QST 713, and Cinnamon Oil 8%+Clove Oil 2% also significantly inhibited M. oryzae. Under field conditions, C. curassavica (10%), A. marmelos (15%), C. gigantea (5%); B.cereus OG2L; B.subtilis OG2A; Proineb and Trifloxystrobin+Tebuconazole were effective in reducing disease in addition to yield enhancement.Conclusion: Overall, the plant extracts (C. curassavica at 10%, A. marmelos at 15%, C. gigantea at 5%); bio-agents (B. cereus OG2L, B. subtilis OG2A both at 2g/l), and new generation fungicides Antracol 70WP (Proineb) at 2.5 g/l and Nativo 75 WG (Trifloxystrobin+Tebuconazole) at 0.5 g/l provided effective control against blast disease and superior plant growth and yield compared with other treatments and untreated control.
563 Influence of Ultra-high Levels of Carbon Dioxide on Secondary Metabolite Production in Vitro